{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:31:06Z","timestamp":1749493866264},"reference-count":60,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13477","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T06:25:02Z","timestamp":1661408702000},"source":"Crossref","is-referenced-by-count":5,"title":["Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow\u2011up"],"prefix":"10.3892","volume":"24","author":[{"given":"Karen","family":"Belki\u0107","sequence":"first","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institute, SE\u201117176 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Obstetrics\u2011Gynecology Division, Karolinska Institute, Stockholm, SE\u201117176 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Alder","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Obstetrics\u2011Gynecology Division, Karolinska Institute, Stockholm, SE\u201117176 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Mints","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Obstetrics\u2011Gynecology Division, Karolinska Institute, Stockholm, SE\u201117176 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Megyessi","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Obstetrics\u2011Gynecology Division, Karolinska Institute, Stockholm, SE\u201117176 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"key20220923112628_b1-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejogrb.2019.06.006","article-title":"Glandular cell abnormalities in cervical cytology: What has changed in this decade and what has not?","volume":"240","author":"Kumar","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20220923112628_b2-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11864-004-0044-0","article-title":"Adenocarcinoma of the cervix","volume":"5","author":"Schorge","year":"2004","journal-title":"Curr Treat Options Oncol"},{"key":"key20220923112628_b3-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"key20220923112628_b4-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976\u20132000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"key":"key20220923112628_b5-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"182.e1","DOI":"10.1016\/j.ajog.2008.09.012","article-title":"Adenocarcinoma in situ of the uterine cervix: A metaanalysis of 1278 patients evaluating the predictive value of conization margin status","volume":"200","author":"Salani","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key20220923112628_b6-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/AOG.0000000000003761","article-title":"Diagnosis and management of adenocarcinoma in situ: A society of gynecologic oncology evidence-based review and recommendations","volume":"135","author":"Teoh","year":"2020","journal-title":"Obstet Gynecol"},{"key":"key20220923112628_b7-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.5858\/arpa.2014-0633-OA","article-title":"Glandular lesions of the cervix in clinical practice A cytology, histology, and human papillomavirus correlation study from 2 institutions","volume":"139","author":"Miller","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"key20220923112628_b8-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1097\/IGC.0000000000000260","article-title":"Adenocarcinoma in situ of the uterine cervix-a systematic review","volume":"24","author":"Baalbergen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"key20220923112628_b9-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1034\/j.1600-0412.2003.00263.x","article-title":"Adenocarcinoma of the uterine cervix: The presence of human papillomavirus and the method of detection","volume":"82","author":"Andersson","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key20220923112628_b10-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"i276","DOI":"10.1136\/bmj.i276","article-title":"Risk of invasive cervical cancer after atypical glandular cells in cervical screening: Nationwide cohort study","volume":"352","author":"Wang","year":"2016","journal-title":"BMJ"},{"key":"key20220923112628_b11-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"e017070","DOI":"10.1136\/bmjopen-2017-017070","article-title":"Risk of high-grade lesions after atypical glandular cells in cervical screening: A population-based cohort study","volume":"7","author":"Norman","year":"2017","journal-title":"BMJ Open"},{"key":"key20220923112628_b12-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"key20220923112628_b13-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"17.e1","DOI":"10.1016\/j.ajog.2009.01.005","article-title":"Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping","volume":"201","author":"Brismar","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key20220923112628_b14-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20220923112628_b15-ol-24-04-13477","first-page":"346","article-title":"High-risk human papillomavirus E6\/E7 mRNA and L1 DNA as markers of residual\/recurrent cervical intraepithelial neoplasia","volume":"28","author":"Persson","year":"2012","journal-title":"Oncol Rep"},{"key":"key20220923112628_b16-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejogrb.2016.12.018","article-title":"HPV-based strategy in follow-up of patients treated for high-grade cervical intra-epithelial neoplasia: 5-year results in a public health surveillance setting","volume":"210","author":"Garutti","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20220923112628_b17-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/aogs.13325","article-title":"HPV-testing versus HPV-cytology co-testing to predict the outcome after conization","volume":"97","author":"Bruhn","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key20220923112628_b18-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jcv.2013.08.006","article-title":"Prevalence and genotype distribution of human papillomavirus in cytology specimens containing atypical glandular cells: A case-control study","volume":"58","author":"Namugenyi","year":"2013","journal-title":"J Clin Virol"},{"key":"key20220923112628_b19-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20220923112628_b20-ol-24-04-13477","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cncr.31788","article-title":"The impact of HPV status on development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at baseline: 9-year Swedish nested case-control follow-up study","volume":"125","author":"Fr\u00f6berg","year":"2019","journal-title":"Cancer"},{"key":"key20220923112628_b21-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000334199","article-title":"Type-specific Human Papillomavirus DNA detected in atypical glandular cell Pap tests","volume":"56","author":"Mulhem","year":"2012","journal-title":"Acta Cytol"},{"key":"key20220923112628_b22-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/PGP.0b013e318190ed27","article-title":"Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ","volume":"28","author":"Rabelo-Santos","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"key20220923112628_b23-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.32340","article-title":"Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008- 2015","volume":"146","author":"Cleveland","year":"2019","journal-title":"Int J Cancer"},{"key":"key20220923112628_b24-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3892\/ol.2021.12945","article-title":"Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment","volume":"22","author":"Andersson","year":"2021","journal-title":"Oncol Lett"},{"key":"key20220923112628_b25-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3892\/ol.2021.12501","article-title":"Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia","volume":"21","author":"\u00d6stensson","year":"2021","journal-title":"Oncol Lett"},{"key":"key20220923112628_b26-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"172.e1","DOI":"10.1016\/j.ajog.2019.08.042","article-title":"Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16 year follow-up study","volume":"222","author":"Alder","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"key20220923112628_b27-ol-24-04-13477","article-title":"Prevention of cervical cancer in countries with high and low incidence of the disease","volume-title":"Doctoral Dissertation","author":"Alder","year":"2018"},{"key":"key20220923112628_b28-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygyno.2013.03.015","article-title":"Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix","volume":"129","author":"Costales","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key20220923112628_b29-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ajo.13047","article-title":"Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study","volume":"60","author":"Tan","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"key20220923112628_b30-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"195.e1","DOI":"10.1016\/j.ajog.2007.04.035","article-title":"Cervical adenocarcinoma in situ: The predictive value of conization margin status","volume":"197","author":"Young","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"key20220923112628_b31-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ygyno.2007.03.016","article-title":"Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix","volume":"106","author":"Costa","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20220923112628_b32-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ygyno.2011.11.039","article-title":"Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: An analysis of 166 cases","volume":"124","author":"Costa","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20220923112628_b33-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ygyno.2014.09.022","article-title":"Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix","volume":"135","author":"Kong","year":"2014","journal-title":"Gynecol Oncol"},{"key":"key20220923112628_b34-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: A systematic review and meta-analysis","volume":"18","author":"Arbyn","year":"2017","journal-title":"Lancet Oncol"},{"key":"key20220923112628_b35-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejogrb.2015.04.005","article-title":"The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ","volume":"190","author":"Song","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20220923112628_b36-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ijc.10080","article-title":"Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN)","volume":"98","author":"Acladious","year":"2002","journal-title":"Int J Cancer"},{"key":"key20220923112628_b37-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"e3042026","DOI":"10.17061\/phrp3042026","article-title":"How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia","volume":"30","author":"Feletto","year":"2020","journal-title":"Public Health Res Pract"},{"key":"key20220923112628_b38-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000509546","article-title":"The impact of the COVID-19 pandemic and the associated Belgian governmental measures on cancer screening, surgical pathology and cytopathology","volume":"88","author":"de Pelsemaeker","year":"2021","journal-title":"Pathobiology"},{"key":"key20220923112628_b39-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/s41416-021-01261-9","article-title":"Effects of cancer screening restart strategies after COVID-19 disruption","volume":"124","author":"Kregting","year":"2021","journal-title":"Br J Cancer"},{"key":"key20220923112628_b40-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"109","DOI":"10.15585\/mmwr.mm7004a1","article-title":"Impact of COVID-19 on cervical cancer screening rates among women aged 21\u201365 in a large integrated health care system-Southern California January 1-September 30, 2019 and January 1-September 30, 2020","volume":"70","author":"Miller","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key20220923112628_b41-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/cncr.33274","article-title":"The future of cancer screening after COVID-19 may be at home","volume":"127","author":"Gorin","year":"2021","journal-title":"Cancer"},{"key":"key20220923112628_b42-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13048-020-00711-x","article-title":"Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: A single-center experience","volume":"13","author":"Nogami","year":"2020","journal-title":"J Ovarian Res"},{"key":"key20220923112628_b43-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/09691413211001097","article-title":"Impact of COVID-19-related care disruptions on cervical cancer screening in the United States","volume":"28","author":"Burger","year":"2021","journal-title":"J Med Screen"},{"key":"key20220923112628_b44-ol-24-04-13477","article-title":"Covid-19: Challenges and Opportunities for Cancer Screening: An example from cervical cancer in Sweden","author":"Dillner","year":"2021"},{"key":"key20220923112628_b45-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13027-020-00325-4","article-title":"Designing low-cost, accurate cervical screening strategies that take into account COVID-19: A role for self-sampled HPV typing","volume":"15","author":"Ajenifuja","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"key20220923112628_b46-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/ijgc-2020-001617","article-title":"European federation for colposcopy (EFC) European society of gynaecological oncology (SGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic","volume":"30","author":"Ciavattini","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"key20220923112628_b47-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ajog.2020.06.006","article-title":"Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice","volume":"223","author":"Cohen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"key20220923112628_b48-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/jnci\/djaa089","article-title":"How the Corona disease-2019 may improve care: Rethinking cervical cancer prevention","volume":"113","author":"Feldman","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"key20220923112628_b49-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: A meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20220923112628_b50-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfill criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key20220923112628_b51-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jcv.2016.06.016","article-title":"Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections","volume":"82","author":"Jentschke","year":"2016","journal-title":"J Clin Virol"},{"key":"key20220923112628_b52-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijgo.12538","article-title":"Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women","volume":"142","author":"Bergengren","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"key20220923112628_b53-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/aogs.12143","article-title":"Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program","volume":"92","author":"\u00d6stensson","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key20220923112628_b54-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10900-014-9931-x","article-title":"Perceptions of mailed HPV self-testing among women at higher risk for cervical cancer","volume":"39","author":"Galbraith","year":"2014","journal-title":"J Community Health"},{"key":"key20220923112628_b55-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12889-016-3474-2","article-title":"HPV testing: A mixed-method approach to understand why women prefer self-collection in a middle-income country","volume":"16","author":"Arrossi","year":"2016","journal-title":"BMC Public Health"},{"key":"key20220923112628_b56-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jrh.12136","article-title":"Barriers and facilitators to cervical cancer screening among women in rural Ontario, Canada: The role of self-collected HPV testing","volume":"32","author":"Racey","year":"2016","journal-title":"J Rural Health"},{"key":"key20220923112628_b57-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1186\/s12889-016-3564-1","article-title":"Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada","volume":"16","author":"Vahabi","year":"2016","journal-title":"BMC Public Health"},{"key":"key20220923112628_b58-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/jwh.2016.5965","article-title":"Clinician and patient acceptability of self-collected human papillomavirus testing for cervical cancer screening","volume":"26","author":"Mao","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"key":"key20220923112628_b59-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13187-019-01608-0","article-title":"Acceptance of self-sampling among long-term cervical screening non-attenders with HPV positive results: Promising opportunity for specific cancer education","volume":"36","author":"Andersson","year":"2021","journal-title":"J Cancer Educ"},{"key":"key20220923112628_b60-ol-24-04-13477","doi-asserted-by":"publisher","first-page":"e0199038","DOI":"10.1371\/journal.pone.0199038","article-title":"Is self-sampling to test for HPV an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?","volume":"13","author":"Andersson","year":"2018","journal-title":"PLoS One"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T04:58:00Z","timestamp":1700974680000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,8,25]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13477","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"357"}}